CytoAgents, Inc.
Biotechnology company · Pittsburgh, Pennsylvania, United States
CytoAgents, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2018. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $7 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2023.
CytoAgents at a glance
What does CytoAgents do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $7 million in total (2020 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $7 million sold (2023).
Frequently asked questions about CytoAgents
Where is CytoAgents headquartered?
CytoAgents, Inc. is headquartered in Pittsburgh, Pennsylvania, United States.
What does CytoAgents do?
CytoAgents, Inc. is a biotechnology company.
When was CytoAgents founded?
The earliest incorporation on record for CytoAgents, Inc. is in 2018, according to public company registers.
Similar companies
- Krystal Biotech, Inc.Pittsburgh, Pennsylvania, United States
- Knopp Biosciences LLCPittsburgh, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.